Hypersensitivity reactions associated with 5-hydroxytryptamine3-receptor antagonists: A class effect?

Lancet

Volumn 347, Issue 9001, 1996, Pages 584-585

  Kataja, Vesa ^a,b,d   De Bruijn, Karel M ^c  

^a University Hospital   (Finland)

^b Sandoz Clinical Development Centre   (United Kingdom)

^c Sandoz Pharma Ltd   (Switzerland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GRANISETRON; ONDANSETRON; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ADULT; AGED; ARTICLE; CASE REPORT; CONSTIPATION; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; PRIORITY JOURNAL;

EID: 0030051681     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91275-1     Document Type: Article

References (6)

1. Jones AL, Hill AS, Soukop M, et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483-87.
2. Warr D, Wilan A, Venner P, et al. A randomized, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. Eur J Cancer 1993; 29A (1): 33-36.
3. 3 receptor antagonist, with metoclopramide-containing antiemetic coctail in the prevention of cisplatin-induced emesis. Cancer 1994; 73: 445-54.
4. Grunberg SM, Stevenson LL, Russell CA, et al. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 1989; 7(8): 1137-41.
5. Kossey JL, Kwok KK. Anaphylactoid reactions associated with ondansetron. Ann Pharmacother 1994; 28(9): 1029-30.
6. Chen M, Tanner A, Gallo-Torres H. Anaphylactoid-anaphylactic reactions associated with ondansetron. Ann Intern Med 1993; 119(8): 862.